SCP
SVRA icon

Sivia Capital Partners’s Savara SVRA Stock Holding History

Sivia Capital Partners’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$265K Sell
48,500
-7
-0% -$39 0.05% 378
2025
Q4 		$292K Buy
48,507
+7
+0% +$34 0.06% 416
2025
Q3 		$173K Buy
48,500
+7,000
+17% +$20.7K 0.05% 450
2025
Q2 		$94.6K Buy
41,500
+3,459
+9% +$9.41K 0.03% 421
2025
Q1 		$105K Buy
38,041
+41
+0.1% +$113 0.05% 282
2024
Q4 		$117K Sell
38,000
-2,500
-6% -$8.72K 0.06% 191
2024
Q3 		$172K Buy
40,500
+1,500
+4% +$6.63K 0.1% 198
2024
Q2 		$157K Buy
39,000
+1,500
+4% +$6.67K 0.11% 180
2024
Q1 		$187K Buy
37,500
+1,500
+4% +$7.25K 0.13% 171
2023
Q4 		$169K Buy
+36,000
New +$138K 0.13% 169

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return